MedPath

A clinical trial to study the effects of scapular PNF and scapular stabilization exercises in stroke patients having problem in scapular orientation and functions

Not Applicable
Conditions
Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases
Registration Number
CTRI/2024/07/070123
Lead Sponsor
Sourav Jana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Both male and female patients aged between 40 – 70 years.

2. Presence of scapular dyskinesia according to Kibler’s Lateral Scapular Slide Test.

3. Diagnosed as first ever stroke.

4. Duration of 3 months to 2 years after stroke.

5. According to Modified Ashworth Scale, spasticity grade-1 to grade- 2 in upper extremity.

6. Brunnstorm upper limb recovery stage 3 to 5.

7. Patients with Mini Mental State examination (MMSE) Score = 24.

8. Patient is able to sit independently without support.

Exclusion Criteria

1. Patient having shoulder pathology (supraspinatus or biceps tendinitis, frozen shoulder, fibromyalgia, and shoulder joint arthritis etc.).

2. Shoulder subluxation more than grade 2 in Fingerbreadth Palpation Methods.

3. Previous shoulder injury causing malposition of shoulder or surgery around arm and shoulder girdle.

4. According to Numeric pain rating scale (NPRS) severe shoulder pain = 7.

5. Patients with hemineglect.

6. Patient with uncontrolled hypertension, cardio-respiratory disease.

7. Other neurological disorders affecting upper extremity like Parkinson’s Disease, Peripheral Neuropathies etc.

8. Patients with sensory and global aphasia. 9. Non-cooperative patients and unwilling to participate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Scapular orientation by- Kibler’s Lateral Scapular Slide Test <br/ ><br>2. Upper extremity functions by- Fugl-Meyer Assessment Upper Extremity (FMA UE)Timepoint: 2 times – on day 0 and after 4 weeks of intervention. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath